Abstract:Lung adenocarcinoma is the most common subtype of non-small cell lung cancer and responsible for more than 500,000 deaths per year worldwide. In this study, we aimed to explore the effects of COPB2 in the progression of lung adenocarcinoma and its underlying mechanism. The mRNA and protein levels of COPB2 in tumor tissues and cell lines were determined by qRT-PCR and western blotting analysis. siRNAs and over-expressed vector targeting COPB2 were used to down-regulate and up-regulate COPB2 expression in lung adenocarcinoma cell lines H1975. Cell apoptosis rate, proliferation and tumorigenesis of H1975 cells were determined by flow cytometry analysis, MTT assay and in vivo xenotransplantation assay, respectively. Western blotting and immunofluorescence assays were performed to evaluate the effects of COPB on the expression and subcellular location of YAP. Results showed COPB2 was significantly up-regulated in lung adenocarcinoma tissues and cell lines, which showed a close correlation with advanced clinical symptoms, such as tumor differentiation, TNM stage and the occurrence of lymph node metastasis and distance metastasis. Besides, the overall survival time of patients with high expression of COPB2 was shorter than that of patients with low COPB2 expression. After knockdown of COPB2, cell apoptosis rate was increased, whereas cell proliferation was decreased. Compared with that in the normal lung cell line H1688 cells, YAP1 expression was obviously increased in H1975, and over-expression of COPB2 translocated YAP1 from cytoplasm to nuclear, whereas knockdown of COPB2 showed the opposite effect. Overexpression of COPB2 enhanced cell proliferation, tumorigenesis and inhibited cell apoptosis. However, these effects were abolished when down-regulated YAP1 expression on the base of COPB2 over-expression. In conclusion, the increased expression of COPB2 was significantly correlated with the progression of lung adenocarcinoma. Up-regulation of COPB2 inhibited cell apoptosis and promoted cell growth and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma.

Inhibitory Effect of COPS3 Gene Interferred by RNA on Proliferation of Lung Cancer A549 Cells and Its Mechanism

he effects of RNA-interference-mediated downregulation of COPS3 on the proliferation of lung cancer cell line

The Down-regulation of LINE-1 Encoded ORF-1p Impacts the Characters of A549 Cells

Knockdown of COPS3 inhibits the progress of prostate cancer through reducing phosphorylated p38 MAPK expression and impairs the epithelial-mesenchymal transition process.

Expression Analysis Of Cdc42 In Lung Cancer And Modulation Of Its Expression By Curcumin In Lung Cancer Cell Lines

Overexpression of COPS3 Promotes Clear Cell Renal Cell Carcinoma Progression Via Regulation of Phospho-AKT(Thr308), Cyclin D1 and Caspase-3

RNAi-mediated COPS3 Gene Silencing Inhibits Metastasis of Osteogenic Sarcoma Cells

Inhibition of Lung Cancer by Transfer Ofp53 Gene Using Tie2-mediated Gene Delivery System

COPS3 inhibition promotes cell proliferation blockage and anoikis via regulating PFKFB3 in osteosarcoma cancer cells

MiR‐34b‐3p Represses Cell Proliferation, Cell Cycle Progression and Cell Apoptosis in Non‐small‐cell Lung Cancer (NSCLC) by Targeting CDK4

Upregulation of ATF3 Expression Inhibit the Proliferation of Human Uterine Serous Carcinoma in Vitro

Knockdown of SMAD3 Inhibits the Growth and Enhances the Radiosensitivity of Lung Adenocarcinoma Via P21 in Vitro and in Vivo.

MiR-875 Can Regulate the Proliferation and Apoptosis of Non-Small Cell Lung Cancer Cells Via Targeting SOCS2.

Curcumin Inhibits the Progression of Non-small Cell Lung Cancer by Regulating DMRT3/SLC7A11 Axis

Knockdown of SMAD3 Inhibits the Growth and Enhances the Radiosensitivity of Lung Adenocarcinoma via p21/Cell Cycle in vitro and in vivo

MiR-3188 Inhibits Non-small Cell Lung Cancer Cell Proliferation Through FOXO1-Mediated mTOR-p-PI3K/AKT-c-JUN Signaling Pathway

Upregulation of the Coatomer Protein Complex Subunit Beta 2 (COPB2) Gene Targets Microrna-335-3p in NCI-H1975 Lung Adenocarcinoma Cells to Promote Cell Proliferation and Migration.

COPB2 Promotes Cell Proliferation and Tumorigenesis Through Up-Regulating YAP1 Expression in Lung Adenocarcinoma Cells.

Inhibitory Effect of Epigallocatechin Gallate on the Proliferation of Lewis Lung Cancer Mice and A549 and Calu-3 Lung Cancer Cells

SIRT3 Inhibits Cell Proliferation of Nonsmall Cell Lung Carcinoma by Inducing ROS Production

Effect of COX-2 Gene Silence on Proliferation and Invasion Ability of OS-RC-2 Cell